Friedreich Ataxia Market Analysis By Drug Class(ACE Inhibitors, Beta Blockers, Diuretics, Para-Benzoquinone), By Route of Administration(Oral, Injectable), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User(Clinics, Hospitals, Diagnostic Centers) & Forecast 2024-2035
- PUBLISHED ON
- 10/11/2022
- NO OF PAGES
- 219
- CATEGORY
- Healthcare & Life Sciences
The global Friedreich’s Ataxia market size was valued at USD 750 million in 2021 and is projected to reach around USD 2,060 million in 2030 exhibiting a CAGR of 12% in the forecasted period.
The fast research and development activities for manufacturing latest therapeutics for Friedreich's Ataxia treatment, rising inorganic business growth strategies such as acquisitions, collaborations, and others among market players, are expected to upsurge the market growth. However, problems faced during planning and conducting clinical trials for development of Freidreich's Ataxia treatment are projected to hinder the growth of the market in the forecasted period.
Growing research and development activities for manufacturing of new Friedreich’s ataxia therapeutics is estimated to drive the market growth over the forecasted period. For instance, as per an article published in the Neurobiology of Disease journal, in January 2021, an oral drug called leriglitazone had presented benefits in handling Friedrich's ataxia in cellular and animal models. Leriglitazone is produced by Minoryx Therapeutics which is presently in innovative Phase 2/3 of clinical trials for the cure of Friedrich's ataxia. Leriglitazone re-establishes mitochondrial function which is normally hindered owing to the deficiency of mitochondrial protein frataxin (FXN) in Friedreich's ataxia disease. Moreover, in February 2022, Design Therapeutics, Inc. announced that it is presently showing Phase 1 clinical trial of its investigational drug DT-216, an intravenous (IV) injection for the treatment of Friedreich's Ataxia and this clinical trial study is projected to be finalized by December 2022. Major players functioning in market are aiming on attaining regulatory approval of their Friedreich’s ataxia drugs, which is anticipated to drive growth of the global Friedreich’s ataxia market during the forecast period.
High burden of Friedreich’s ataxia is anticipated to drive growth of the Friedreich’s ataxia market across the forecasted period. For instance, as per the data published by the Ataxia UK, a charity registered in Scotland and England & Wales in November 2020, it was projected that the incidence of Friedreich’s ataxia established on carrier frequency of 1 in 85 was 1: 29,000 in Europe in 2020. Moreover, according to the research conducted till date, Friedreich’s Ataxia affects 1 in every 40,000 people.
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus) was stated as a global pandemic by the World Health Organization (WHO), which describes this SARS-CoV-2 infection as novel Coronavirus (COVID-19). As per the Coronavirus (COVID-19), Weekly Epidemiological Update by the World Health Organization, COVID-19 has spread throughout the globe infecting more than 519 million population intending to over 6.3 million deaths as of May 15, 2022. The adverse impact of COVID-19 on the healthcare domain is vast and it has considerably disrupted the healthcare industries’ complete supply chain, from raw materials to development and delivery. Also, the COVID-19 pandemic had a negative impact on the overall growth of the Friedreich’s ataxia market, due to movement limitations and lockdowns.
Likewise, demand and supply for Friedreich’s ataxia therapeutics was disturbed, due to termination of clinical trials intended at developing treatment drugs for Freidreich’s ataxia, and disrupted supply of Friedreich’s ataxia treatment drugs through the lockdown. Furthermore, physiotherapy, rehabilitation programs, physical training, etc. for managing Friedreich’s ataxia was stopped during the lockdown. For instance, as per the electronic survey done amongst Friedreich ataxia (FA) patients in Italy and issued in the Cerebellum & Ataxias journal, an open access scientific journal in January 2021, it was found that the number of patients undertaking physiotherapy was declined by 72.2% due to the COVID-19 lockdown. As per the same source, more than 60% of Friedreich ataxia patients described worsening of their health in lack of physiotherapy during COVID-19 lockdown.
Drug Class Insights
On the basis of drug class, the ACE inhibitors leads the market with the maximum share in due to higher safety and it decreases the burden of the heart, and pacemakers or medicines can stabilize an arrhythmic heartbeat.
End User Insights
On the basis of the end user, the hospitals segment accounts for the maximum growth of the Friedreich’s Ataxia market. The several management activities such as speech therapy, physical therapy, occupational therapy, and surgery are conducted in the hospitals. Moreover, people prefer hospitals over other medication centers due to availability of better infrastructure and equipment.
Region Insights
North America accounts for the maximum market share owing to the increasing awareness for Friedrich’s ataxia and growing funding activities by the U.S. FDA to speed up the research activities aiming rare diseases.
Europe is also projected to grow owing to increasing initiative by market companies and the climbing number of orphan drug descriptions to a drug developed for occasional disease treatment.
Asia-Pacific is expected to grow at the fastest rate owing to rising patients focus concerning effective disease diagnosis and growing government focus for the growth of pharmaceutical industries.
Key Companies Insights
The market for Friedreich’s Ataxia is moderately competitive. With the rising applications of Friedreich’s Ataxia, new players are considering to enter the market. The companies are also involved in activities like joint ventures, mergers, acquisitions, partnerships, and collaborations. These activities aid in growing the effect of the players in the Friedreich’s Ataxia market, ultimately boosting the market growth. Some of the key companies working in the global Friedreich’s Ataxia market include:
· Reata Pharmaceuticals, Inc.
· Retrotope Inc.
· Minoryx, PTC Therapeutics
· Design Therapeutics, Inc.
· Larimar Therapeutics, Inc.
· Jupiter Neurosciences, Inc.
· Lexeo Therapeutics
· Zydus Lifesciences Ltd.
· Cipla Limited
· GlaxoSmithKline Plc.
· Aurobindo Pharma Ltd.
· Sun Pharmaceutical Industries Ltd.
· Torrent Pharmaceuticals Ltd.
· Intas Pharmaceuticals Ltd.
· Other players
Some of the Recent Developments:
· In February 2022, Design Therapeutics, Inc. announced that it is currently conducting Phase 1 clinical trial of its investigational drug DT-216, an intravenous (IV) injection for the cure of Friedreich's Ataxia.
· In March 2022, Stealth BioTherapeutics Inc. received Orphan Drug Designation from the U.S. Food and Drug Administration (US FDA) Office of Orphan Products Development for its drug Elamipretide, which is designated for the treatment of Friedreich's ataxia.
Segments
By Drug Class
· ACE Inhibitors
· Beta Blockers
· Diuretics
· Para-Benzoquinone
· Others
By Route of Administration
· Oral
· Injectable
By Distribution Channel
· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies
By End User
· Clinics
· Hospitals
· Diagnostic Centers
· Others
Global Friedreich Ataxia Market: Regional AnalysisAll the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Friedreich Ataxia market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Global Friedreich Ataxia Market: Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Friedreich Ataxia Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of Friedreich Ataxia
1.3 Friedreich Ataxia Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of Friedreich Ataxia
1.4.2 Applications of Friedreich Ataxia
1.5 Market Exchange Rate
2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source
3 Market Competition Analysis
3.1 HaEmek Medical Center Market Performance Analysis
3.1.1 HaEmek Medical Center Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 HaEmek Medical Center Sales, Value, Price, Gross Margin 2016-2021
3.2 Shire Plc Market Performance Analysis
3.2.1 Shire Plc Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 Shire Plc Sales, Value, Price, Gross Margin 2016-2021
3.3 InMed Pharmaceuticals Inc. Market Performance Analysis
3.3.1 InMed Pharmaceuticals Inc. Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 InMed Pharmaceuticals Inc. Sales, Value, Price, Gross Margin 2016-2021
3.4 Scioderm, Inc. Market Performance Analysis
3.4.1 Scioderm, Inc. Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Scioderm, Inc. Sales, Value, Price, Gross Margin 2016-2021
3.5 Azienda Ospedaliera - Universitaria di Modena Market Performance Analysis
3.5.1 Azienda Ospedaliera - Universitaria di Modena Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 Azienda Ospedaliera - Universitaria di Modena Sales, Value, Price, Gross Margin 2016-2021
3.6 Federal University of Sao Paulo Market Performance Analysis
3.6.1 Federal University of Sao Paulo Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 Federal University of Sao Paulo Sales, Value, Price, Gross Margin 2016-2021
3.7 The Cornea and Laser Eye Institute Market Performance Analysis
3.7.1 The Cornea and Laser Eye Institute Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 The Cornea and Laser Eye Institute Sales, Value, Price, Gross Margin 2016-2021
3.8 Al-Noor Eye Hospital Market Performance Analysis
3.8.1 Al-Noor Eye Hospital Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Al-Noor Eye Hospital Sales, Value, Price, Gross Margin 2016-2021
3.9 Stratatech Corporation Market Performance Analysis
3.9.1 Stratatech Corporation Basic Information
3.9.2 Product and Service Analysis
3.9.3 Strategies for Company to Deal with the Impact of COVID-19
3.9.4 Stratatech Corporation Sales, Value, Price, Gross Margin 2016-2021
3.10 Democritus University of Thrace Market Performance Analysis
3.10.1 Democritus University of Thrace Basic Information
3.10.2 Product and Service Analysis
3.10.3 Strategies for Company to Deal with the Impact of COVID-19
3.10.4 Democritus University of Thrace Sales, Value, Price, Gross Margin 2016-2021
3.11 GlaxoSmithKline Plc Market Performance Analysis
3.11.1 GlaxoSmithKline Plc Basic Information
3.11.2 Product and Service Analysis
3.11.3 Strategies for Company to Deal with the Impact of COVID-19
3.11.4 GlaxoSmithKline Plc Sales, Value, Price, Gross Margin 2016-2021
3.12 Karus Therapeutics Limited Market Performance Analysis
3.12.1 Karus Therapeutics Limited Basic Information
3.12.2 Product and Service Analysis
3.12.3 Strategies for Company to Deal with the Impact of COVID-19
3.12.4 Karus Therapeutics Limited Sales, Value, Price, Gross Margin 2016-2021
3.13 Fibrocell Science, Inc. Market Performance Analysis
3.13.1 Fibrocell Science, Inc. Basic Information
3.13.2 Product and Service Analysis
3.13.3 Strategies for Company to Deal with the Impact of COVID-19
3.13.4 Fibrocell Science, Inc. Sales, Value, Price, Gross Margin 2016-2021
3.14 RegeneRx Biopharmaceuticals, Inc.. Market Performance Analysis
3.14.1 RegeneRx Biopharmaceuticals, Inc.. Basic Information
3.14.2 Product and Service Analysis
3.14.3 Strategies for Company to Deal with the Impact of COVID-19
3.14.4 RegeneRx Biopharmaceuticals, Inc.. Sales, Value, Price, Gross Margin 2016-2021
3.15 Emory University Market Performance Analysis
3.15.1 Emory University Basic Information
3.15.2 Product and Service Analysis
3.15.3 Strategies for Company to Deal with the Impact of COVID-19
3.15.4 Emory University Sales, Value, Price, Gross Margin 2016-2021
3.16 Azienda Ospedaliera Universitaria Senese Market Performance Analysis
3.16.1 Azienda Ospedaliera Universitaria Senese Basic Information
3.16.2 Product and Service Analysis
3.16.3 Strategies for Company to Deal with the Impact of COVID-19
3.16.4 Azienda Ospedaliera Universitaria Senese Sales, Value, Price, Gross Margin 2016-2021
3.17 Department of Health, South Africa Market Performance Analysis
3.17.1 Department of Health, South Africa Basic Information
3.17.2 Product and Service Analysis
3.17.3 Strategies for Company to Deal with the Impact of COVID-19
3.17.4 Department of Health, South Africa Sales, Value, Price, Gross Margin 2016-2021
3.18 Birken AG Market Performance Analysis
3.18.1 Birken AG Basic Information
3.18.2 Product and Service Analysis
3.18.3 Strategies for Company to Deal with the Impact of COVID-19
3.18.4 Birken AG Sales, Value, Price, Gross Margin 2016-2021
3.19 Isfahan University of Medical Sciences Market Performance Analysis
3.19.1 Isfahan University of Medical Sciences Basic Information
3.19.2 Product and Service Analysis
3.19.3 Strategies for Company to Deal with the Impact of COVID-19
3.19.4 Isfahan University of Medical Sciences Sales, Value, Price, Gross Margin 2016-2021
4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global Friedreich Ataxia Production and Value by Type
4.1.1 Global Friedreich Ataxia Production by Type 2016-2021
4.1.2 Global Friedreich Ataxia Market Value by Type 2016-2021
4.2 Global Friedreich Ataxia Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 Liquid Crystal Display (LCD) Displays Market Production, Value and Growth Rate
4.2.2 NFC-enabled Electronic Shelf Labels Market Production, Value and Growth Rate
4.2.3 E papers Displays Market Production, Value and Growth Rate
4.2.4 Other Market Production, Value and Growth Rate
4.3 Global Friedreich Ataxia Production and Value Forecast by Type
4.3.1 Global Friedreich Ataxia Production Forecast by Type 2022-2030
4.3.2 Global Friedreich Ataxia Market Value Forecast by Type 2022-2030
4.4 Global Friedreich Ataxia Market Production, Value and Growth Rate by Type Forecast 2022-2030
4.4.1 Liquid Crystal Display (LCD) Displays Market Production, Value and Growth Rate Forecast
4.4.2 NFC-enabled Electronic Shelf Labels Market Production, Value and Growth Rate Forecast
4.4.3 E papers Displays Market Production, Value and Growth Rate Forecast
4.4.4 Other Market Production, Value and Growth Rate Forecast
5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global Friedreich Ataxia Consumption and Value by Application
5.1.1 Global Friedreich Ataxia Consumption by Application 2016-2021
5.1.2 Global Friedreich Ataxia Market Value by Application 2016-2021
5.2 Global Friedreich Ataxia Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 Hypermarkets Market Consumption, Value and Growth Rate
5.2.2 Supermarkets Market Consumption, Value and Growth Rate
5.2.3 Others Market Consumption, Value and Growth Rate
5.3 Global Friedreich Ataxia Consumption and Value Forecast by Application
5.3.1 Global Friedreich Ataxia Consumption Forecast by Application 2022-2030
5.3.2 Global Friedreich Ataxia Market Value Forecast by Application 2022-2030
5.4 Global Friedreich Ataxia Market Consumption, Value and Growth Rate by Application Forecast 2022-2030
5.4.1 Hypermarkets Market Consumption, Value and Growth Rate Forecast
5.4.2 Supermarkets Market Consumption, Value and Growth Rate Forecast
5.4.3 Others Market Consumption, Value and Growth Rate Forecast
6 Global Friedreich Ataxia by Region, Historical Data and Market Forecasts
6.1 Global Friedreich Ataxia Sales by Region 2016-2021
6.2 Global Friedreich Ataxia Market Value by Region 2016-2021
6.3 Global Friedreich Ataxia Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global Friedreich Ataxia Sales Forecast by Region 2022-2030
6.5 Global Friedreich Ataxia Market Value Forecast by Region 2022-2030
6.6 Global Friedreich Ataxia Market Sales, Value and Growth Rate Forecast by Region 2022-2030
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa
7 United State Market Size Analysis 2016-2026
7.1 United State Friedreich Ataxia Value and Market Growth 2016-2021
7.2 United State Friedreich Ataxia Sales and Market Growth 2016-2021
7.3 United State Friedreich Ataxia Market Value Forecast 2022-2030
8 Canada Market Size Analysis 2016-2026
8.1 Canada Friedreich Ataxia Value and Market Growth 2016-2021
8.2 Canada Friedreich Ataxia Sales and Market Growth 2016-2021
8.3 Canada Friedreich Ataxia Market Value Forecast 2022-2030
9 Germany Market Size Analysis 2016-2026
9.1 Germany Friedreich Ataxia Value and Market Growth 2016-2021
9.2 Germany Friedreich Ataxia Sales and Market Growth 2016-2021
9.3 Germany Friedreich Ataxia Market Value Forecast 2022-2030
10 UK Market Size Analysis 2016-2026
10.1 UK Friedreich Ataxia Value and Market Growth 2016-2021
10.2 UK Friedreich Ataxia Sales and Market Growth 2016-2021
10.3 UK Friedreich Ataxia Market Value Forecast 2022-2030
11 France Market Size Analysis 2016-2026
11.1 France Friedreich Ataxia Value and Market Growth 2016-2021
11.2 France Friedreich Ataxia Sales and Market Growth 2016-2021
11.3 France Friedreich Ataxia Market Value Forecast 2022-2030
12 Italy Market Size Analysis 2016-2026
12.1 Italy Friedreich Ataxia Value and Market Growth 2016-2021
12.2 Italy Friedreich Ataxia Sales and Market Growth 2016-2021
12.3 Italy Friedreich Ataxia Market Value Forecast 2022-2030
13 Spain Market Size Analysis 2016-2026
13.1 Spain Friedreich Ataxia Value and Market Growth 2016-2021
13.2 Spain Friedreich Ataxia Sales and Market Growth 2016-2021
13.3 Spain Friedreich Ataxia Market Value Forecast 2022-2030
14 Russia Market Size Analysis 2016-2026
14.1 Russia Friedreich Ataxia Value and Market Growth 2016-2021
14.2 Russia Friedreich Ataxia Sales and Market Growth 2016-2021
14.3 Russia Friedreich Ataxia Market Value Forecast 2022-2030
15 China Market Size Analysis 2016-2026
15.1 China Friedreich Ataxia Value and Market Growth 2016-2021
15.2 China Friedreich Ataxia Sales and Market Growth 2016-2021
15.3 China Friedreich Ataxia Market Value Forecast 2022-2030
16 Japan Market Size Analysis 2016-2026
16.1 Japan Friedreich Ataxia Value and Market Growth 2016-2021
16.2 Japan Friedreich Ataxia Sales and Market Growth 2016-2021
16.3 Japan Friedreich Ataxia Market Value Forecast 2022-2030
17 South Korea Market Size Analysis 2016-2026
17.1 South Korea Friedreich Ataxia Value and Market Growth 2016-2021
17.2 South Korea Friedreich Ataxia Sales and Market Growth 2016-2021
17.3 South Korea Friedreich Ataxia Market Value Forecast 2022-2030
18 Australia Market Size Analysis 2016-2026
18.1 Australia Friedreich Ataxia Value and Market Growth 2016-2021
18.2 Australia Friedreich Ataxia Sales and Market Growth 2016-2021
18.3 Australia Friedreich Ataxia Market Value Forecast 2022-2030
19 Thailand Market Size Analysis 2016-2026
19.1 Thailand Friedreich Ataxia Value and Market Growth 2016-2021
19.2 Thailand Friedreich Ataxia Sales and Market Growth 2016-2021
19.3 Thailand Friedreich Ataxia Market Value Forecast 2022-2030
20 Brazil Market Size Analysis 2016-2026
20.1 Brazil Friedreich Ataxia Value and Market Growth 2016-2021
20.2 Brazil Friedreich Ataxia Sales and Market Growth 2016-2021
20.3 Brazil Friedreich Ataxia Market Value Forecast 2022-2030
21 Argentina Market Size Analysis 2016-2026
21.1 Argentina Friedreich Ataxia Value and Market Growth 2016-2021
21.2 Argentina Friedreich Ataxia Sales and Market Growth 2016-2021
21.3 Argentina Friedreich Ataxia Market Value Forecast 2022-2030
22 Chile Market Size Analysis 2016-2026
22.1 Chile Friedreich Ataxia Value and Market Growth 2016-2021
22.2 Chile Friedreich Ataxia Sales and Market Growth 2016-2021
22.3 Chile Friedreich Ataxia Market Value Forecast 2022-2030
23 South Africa Market Size Analysis 2016-2026
23.1 South Africa Friedreich Ataxia Value and Market Growth 2016-2021
23.2 South Africa Friedreich Ataxia Sales and Market Growth 2016-2021
23.3 South Africa Friedreich Ataxia Market Value Forecast 2022-2030
24 Egypt Market Size Analysis 2016-2026
24.1 Egypt Friedreich Ataxia Value and Market Growth 2016-2021
24.2 Egypt Friedreich Ataxia Sales and Market Growth 2016-2021
24.3 Egypt Friedreich Ataxia Market Value Forecast 2022-2030
25 UAE Market Size Analysis 2016-2026
25.1 UAE Friedreich Ataxia Value and Market Growth 2016-2021
25.2 UAE Friedreich Ataxia Sales and Market Growth 2016-2021
25.3 UAE Friedreich Ataxia Market Value Forecast 2022-2030
26 Saudi Arabia Market Size Analysis 2016-2026
26.1 Saudi Arabia Friedreich Ataxia Value and Market Growth 2016-2021
26.2 Saudi Arabia Friedreich Ataxia Sales and Market Growth 2016-2021
26.3 Saudi Arabia Friedreich Ataxia Market Value Forecast 2022-2030
27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI